Opioid Elimination Half-Lives
The elimination half-lives of commonly used opioids vary significantly, ranging from minutes for ultra-short-acting agents like remifentanil (10-12 minutes) to over 100 hours for methadone, with most standard opioids falling in the 2-6 hour range.
Standard Opioids (Short-Acting)
Morphine has an elimination half-life of 2-4 hours in adults 1. In pediatric populations, this varies by age: infants 1-3 months show 6.2 hours (range 5-10 hours), infants 6 months-2.5 years show 2.9 hours (1.4-7.8 hours), and children demonstrate 1-2 hours 2.
Hydromorphone and oxycodone have similar pharmacokinetic profiles to morphine when used in equianalgesic doses 1.
Meperidine demonstrates age-dependent half-lives: in infants at 3 months it ranges from 8.2-10.7 hours (range 4.9-31.7 hours), decreasing to 2.3 hours in infants 3-18 months, and 3 hours in children 5-8 years 2.
Codeine has a half-life of approximately 3-4 hours 3.
Fentanyl Family (Ultra-Short to Short-Acting)
Fentanyl shows variable half-lives depending on route and duration of administration. In pediatric patients aged 5 months-4.5 years, the mean half-life is 2.4 hours, but with long-term infusions (0.5-14 years), this extends to 21 hours (range 11-36 hours) 2. For transdermal fentanyl, serum levels take approximately 16 hours to drop to 50% after patch removal 1.
Alfentanil has an elimination half-life of approximately 58 minutes with an equilibration half-life between plasma and effect site of about 1 minute 4, 5.
Remifentanil represents the ultra-short-acting extreme with an elimination half-life of only 9.5-12 minutes and a context-sensitive half-life of approximately 3 minutes even after prolonged infusions 4, 5, 6. This makes it unique among opioids as its offset is essentially independent of infusion duration.
Sufentanil in children 2-8 years has a half-life of 97±42 minutes 2.
Long-Acting Opioids
Methadone is notably complex with marked interindividual variability. Its elimination half-life averages approximately 24 hours with a range of 15-120 hours 3, 1. The equilibration half-life is about 8 minutes 4. This discrepancy between its initial analgesic effect duration (4-6 hours) and its prolonged elimination half-life creates significant risk for drug accumulation with chronic dosing 1.
Tramadol has a mean elimination half-life of approximately 6 hours 7.
Critical Clinical Considerations
Context-sensitive half-time is more clinically relevant than terminal elimination half-life for drugs given by infusion, as it accounts for drug redistribution and accumulation 6. This is particularly important for fentanyl and its analogues.
Age-dependent variations are substantial, particularly in neonates and infants. Neonates show markedly prolonged half-lives: morphine 7.6 hours (range 4.5-13.3 hours), meperidine 23 hours (range 12-39 hours), and fentanyl 1-15 hours 2.
Organ dysfunction significantly affects opioid metabolism. Renal impairment prolongs half-lives of morphine and its metabolites, while hepatic dysfunction affects all opioids but particularly methadone and fentanyl 2, 8.
Active metabolites must be considered. Morphine-6-glucuronide (M6G) has an exceptionally long equilibration half-life of approximately 7 hours, making it the slowest opioid with respect to plasma-effect site transfer 4. This is clinically significant in renal impairment where M6G accumulates.
The wide variability in methadone's half-life (15-120 hours) makes it unsuitable for non-specialist practitioners and requires careful monitoring to avoid accumulation and toxicity 1. Methadone should not be dosed more frequently than every 8 hours despite its 4-6 hour analgesic duration 1.